Skip to content
Est. 1998 proudly celebrating our 27th year of championing American business
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

BioNexus Gene Lab Corp

  • KUALA LUMPUR,
  • Public · NASDAQ: BGLC
  • 1 employees
$5.3MMarket cap
$7.4MRevenue · FY2025
-$3.0MNet income
1Employees
BGLCNASDAQ
2020IPO

About BioNexus Gene Lab Corp

BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$7.4M
Net income
-$3.0M
Total assets
$9.3M
Market cap
$5.3M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: BGLC

15-minute delayed · data by Polygon.io

Market cap
$5.3M
Open
Day range
Prev close
Volume
IPO date
Mar 11, 2020

Market data by Polygon.io · prices are 15-minute delayed

No reviews yet. Be the first to review BioNexus Gene Lab Corp.

Write a review
Explore

Similar companies

Browse all →